Details for New Drug Application (NDA): 021861
✉ Email this page to a colleague
The generic ingredient in PATANASE is olopatadine hydrochloride. There are seventeen drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the olopatadine hydrochloride profile page.
Summary for 021861
Tradename: | PATANASE |
Applicant: | Novartis |
Ingredient: | olopatadine hydrochloride |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 021861
Suppliers and Packaging for NDA: 021861
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
PATANASE | olopatadine hydrochloride | SPRAY, METERED;NASAL | 021861 | NDA AUTHORIZED GENERIC | Sandoz Inc | 61314-320 | 61314-320-01 | 1 BOTTLE in 1 CARTON (61314-320-01) / 30500 uL in 1 BOTTLE |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SPRAY, METERED;NASAL | Strength | 0.665MG/SPRAY | ||||
Approval Date: | Apr 15, 2008 | TE: | RLD: | Yes |
Expired US Patents for NDA 021861
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Novartis | PATANASE | olopatadine hydrochloride | SPRAY, METERED;NASAL | 021861-001 | Apr 15, 2008 | ⤷ Sign Up | ⤷ Sign Up |
Novartis | PATANASE | olopatadine hydrochloride | SPRAY, METERED;NASAL | 021861-001 | Apr 15, 2008 | ⤷ Sign Up | ⤷ Sign Up |
Novartis | PATANASE | olopatadine hydrochloride | SPRAY, METERED;NASAL | 021861-001 | Apr 15, 2008 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription